CSS
ARKG icon

Cubist Systematic Strategies’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cubist Systematic Strategies’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.25M Buy
117,000
+81,700
+231% +$2.06M 0.02% 1258
2025
Q2 		$860K Buy
+35,300
New +$774K ﹤0.01% 2020
2025
Q1 		– Sell
-12,200
Closed -$287K – 2835
2024
Q4 		$287K Buy
+12,200
New +$300K ﹤0.01% 2425
2024
Q3 		– Sell
-1,600
Closed -$37.6K – 2964
2024
Q2 		$37.6K Buy
+1,600
New +$40.4K ﹤0.01% 2732

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cubist Systematic Strategies's ARKG Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 19,061 shares — an estimated $481K sold.

Cubist Systematic Strategies first reported a position in ARKG in Q1 2024 and held it in 1 quarter. The position peaked at $548K in Q1 2024. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 19,061 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $481K.
  • Cubist Systematic Strategies first reported a position in ARK Genomic Revolution ETF in Q1 2024 and held it in 1 quarter.
  • Cubist Systematic Strategies's ARK Genomic Revolution ETF position peaked at $548K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.